Preface |
|
xii | |
Abbreviations |
|
xiii | |
Format and Content of a Quickview Chart |
|
xxi | |
|
List of Charts in Alphabetical Order |
|
|
|
|
1 | (1) |
|
2 Adrenocorticotropic Hormone (ACTH) |
|
|
2 | (1) |
|
3 Alanine Aminotransferase (ALT) |
|
|
3 | (1) |
|
|
4 | (1) |
|
5 Alkaline Phosphatase (ALP) |
|
|
5 | (1) |
|
6 Alpha Fetoprotein (AFp) |
|
|
6 | (1) |
|
|
7 | (1) |
|
|
8 | (1) |
|
9 Amphetamines and Methamphetamines (Urine Drug Screen) |
|
|
9 | (1) |
|
|
10 | (1) |
|
|
11 | (1) |
|
12 Antifactor Xa Activity |
|
|
12 | (1) |
|
13 Antinuclear Antibodies (ANA) |
|
|
13 | (1) |
|
14 Antiphospholipid Antibodies |
|
|
14 | (1) |
|
|
15 | (1) |
|
16 aPTT (Activated Partial Thromboplastin Time) |
|
|
16 | (1) |
|
17 Aspartate Aminotransferase (AST) |
|
|
17 | (1) |
|
|
18 | (1) |
|
19 Barbiturates (Urine Drug Screen) |
|
|
19 | (1) |
|
|
20 | (1) |
|
|
21 | (1) |
|
22 Benzodiazepines (Urine Drug Screen) |
|
|
22 | (1) |
|
23 Benzoylecgonine (Cocaine Metabolite) (Urine Drug Screen) |
|
|
23 | (1) |
|
24 Beta-2-Microglobulin (B2M) |
|
|
24 | (1) |
|
25 Bicarbonate (HCO3)/Total CO2 (Venous) |
|
|
25 | (1) |
|
26 Blood Urea Nitrogen (BUN) |
|
|
26 | (1) |
|
27 B-Type Natriuretic Peptide (BNP) & NT-proBNP |
|
|
27 | (1) |
|
|
28 | (1) |
|
29 CA 125 (Cancer Antigen 125) |
|
|
29 | (1) |
|
30 CA 15-3 (Cancer Antigen 15-3) |
|
|
30 | (1) |
|
31 CA 19-9 (Cancer Antigen 19-9) |
|
|
31 | (1) |
|
32 CA 27.29 (Cancer Antigen 27.29) |
|
|
32 | (1) |
|
|
33 | (2) |
|
|
35 | (1) |
|
35 Carcinoembryonic Antigen (CEA) |
|
|
36 | (1) |
|
36 CD4+ T Lymphocyte Count |
|
|
37 | (1) |
|
|
38 | (1) |
|
|
39 | (1) |
|
39 CK-MB Isoenzyme Subforms (CK-MB1 and CK-MB2) |
|
|
40 | (1) |
|
|
41 | (1) |
|
41 Complement Hemolytic 50% |
|
|
42 | (1) |
|
|
43 | (1) |
|
|
44 | (1) |
|
|
45 | (1) |
|
45 Cosyntropin Stimulation Test |
|
|
46 | (1) |
|
|
47 | (1) |
|
47 C-Reactive Protein (CRP) |
|
|
48 | (1) |
|
|
49 | (2) |
|
|
51 | (1) |
|
|
52 | (1) |
|
51 Delta-9-Tetrahydrocannabinol-9-Carbozylic Acid (THC) (Urine Drug Screen) |
|
|
53 | (1) |
|
|
54 | (1) |
|
|
55 | (1) |
|
54 Erythrocyte Sedimentation Rate (ESR) |
|
|
56 | (1) |
|
|
57 | (1) |
|
56 Estrogen and Progesterone Receptors |
|
|
58 | (1) |
|
|
59 | (1) |
|
|
60 | (1) |
|
|
61 | (1) |
|
60 FEV1 (Forced Expiratory Volume in 1 Second) |
|
|
62 | (1) |
|
|
63 | (1) |
|
|
64 | (1) |
|
63 Fractional Excretion of Sodium (FENa) |
|
|
65 | (1) |
|
64 Fractional Excretion of Urea (FEUrea) |
|
|
66 | (1) |
|
|
67 | (1) |
|
|
68 | (1) |
|
67 FSH (Follicle Stimulating Hormone) |
|
|
69 | (1) |
|
68 G6PD (Glucose-6-Phosphate Dehydrogenase) |
|
|
70 | (1) |
|
|
71 | (1) |
|
70 Gamma-Glutamyl Transpeptidase (GGTP) |
|
|
72 | (1) |
|
|
73 | (1) |
|
|
74 | (1) |
|
73 Hemoglobin (Hgb)/Hematocrit (Hct) |
|
|
75 | (2) |
|
74 Heparin-Induced Platelet Antibodies |
|
|
77 | (1) |
|
75 High Density Lipoprotein (HDL) |
|
|
78 | (1) |
|
|
79 | (1) |
|
|
80 | (1) |
|
78 HIV RNA Concentration (Viral Load) |
|
|
81 | (1) |
|
|
82 | (1) |
|
|
83 | (1) |
|
|
84 | (1) |
|
82 Human Chorionic Gonadotropin (hCG) |
|
|
85 | (1) |
|
83 Human Epidermal Growth Factor Receptor 2 (HER-2) |
|
|
86 | (1) |
|
84 INR/PT (International Normalized Ratio and Prothrombin Time) |
|
|
87 | (1) |
|
|
88 | (1) |
|
|
89 | (1) |
|
87 LDH (Lactic Acid Dehydrogenase) |
|
|
90 | (1) |
|
88 LH (Luteinizing Hormone) |
|
|
91 | (1) |
|
|
92 | (1) |
|
|
93 | (1) |
|
|
94 | (1) |
|
92 Low Density Lipoprotein (LDL) |
|
|
95 | (1) |
|
|
96 | (1) |
|
94 Lysergic Acid Diethylamide (LSD) (Urine Drug Screen) |
|
|
97 | (1) |
|
|
98 | (2) |
|
|
100 | (1) |
|
|
101 | (1) |
|
98 Mean Corpuscular Hemoglobin Concentration (MCHC) |
|
|
102 | (1) |
|
99 Mean Corpuscular Hgb (MCH) |
|
|
103 | (1) |
|
100 Mean Corpuscular Volume |
|
|
104 | (1) |
|
|
105 | (1) |
|
|
106 | (1) |
|
|
107 | (1) |
|
|
108 | (1) |
|
|
109 | (1) |
|
106 Opiates (Urine Drug Screen) |
|
|
110 | (1) |
|
107 Partial Pressure of Arterial Carbon Dioxide (PaCO2 or PCO2) |
|
|
111 | (1) |
|
108 Partial Pressure of Arterial Oxygen (PaO2 or PO2) |
|
|
112 | (1) |
|
109 PEFR (Peak Expiratory Flow Rate) |
|
|
113 | (1) |
|
110 pH (of Arterial Blood) |
|
|
114 | (1) |
|
111 Phencyclidine (PCP) (Urine Drug Screen) |
|
|
115 | (1) |
|
112 Phenobarbital/Primidone |
|
|
116 | (1) |
|
|
117 | (1) |
|
|
118 | (2) |
|
|
120 | (1) |
|
|
121 | (1) |
|
117 Polymorphonuclear Neutrophils |
|
|
122 | (1) |
|
|
123 | (1) |
|
|
124 | (1) |
|
|
125 | (1) |
|
|
126 | (1) |
|
|
127 | (1) |
|
|
128 | (1) |
|
124 PSA (Prostate-Specific Antigen) |
|
|
129 | (1) |
|
|
130 | (1) |
|
126 RBC Distribution Width (RDW) |
|
|
131 | (1) |
|
127 Red Blood Cells (RBC) |
|
|
132 | (1) |
|
|
133 | (1) |
|
|
134 | (1) |
|
|
135 | (1) |
|
131 Serotonin Release Assay (SRA) |
|
|
136 | (1) |
|
132 Serum Creatinine (SCr) |
|
|
137 | (1) |
|
|
138 | (1) |
|
|
139 | (1) |
|
|
140 | (2) |
|
|
142 | (1) |
|
|
143 | (2) |
|
|
145 | (1) |
|
139 Thiopurine Methyltransferase (TPMT) |
|
|
146 | (1) |
|
140 Thyroid Stimulating Hormone (TSH) |
|
|
147 | (1) |
|
|
148 | (1) |
|
|
149 | (1) |
|
143 Total Iron Binding Capacity (TIBC) |
|
|
150 | (1) |
|
144 Total Serum T3 (Triiodothyronine) |
|
|
151 | (1) |
|
145 Total Serum T4 (Thyroxine) |
|
|
152 | (1) |
|
146 Transferrin Saturation (TSAT) |
|
|
153 | (1) |
|
147 Tricyclic Antidepressant Levels |
|
|
154 | (1) |
|
|
155 | (1) |
|
|
156 | (1) |
|
|
157 | (1) |
|
|
158 | (1) |
|
152 Uridine Diphosphate Glucuronyl Transferase (UGT1 A1) |
|
|
159 | (1) |
|
|
160 | (1) |
|
|
161 | (1) |
|
|
162 | (1) |
|
156 White Blood Cell Count |
|
|
163 | (2) |
|
|
165 | (1) |
Appendix A Statistical Concepts Associated with Diagnosis |
|
166 | (2) |
Appendix B General Information About Assay Modalities |
|
168 | (1) |
Appendix C Tubes for Blood Collection |
|
169 | (1) |
Topic Index |
|
170 | (6) |
Index |
|
176 | |